Proposal for a new diagnostic-therapeutic algorithm  in chronic rhinosinusitis with nasal polyps

Matteo Gelardi; Rossana Giancaspro; Giulia Cintoli; Salvatore Simone Minafra; Salvatore Musto; Michele Cassano

doi:10.23750/abm.v94i4.14152

Proposal for a new diagnostic-therapeutic algorithm in chronic rhinosinusitis with nasal polyps

Authors

Matteo Gelardi Department of Otolaryngology, University of Foggia, Foggia, Italy
Rossana Giancaspro a:1:{s:5:"en_US";s:20:"University of Foggia";}
Giulia Cintoli Department of Otolaryngology, University of Foggia, Foggia, Italy
Salvatore Simone Minafra Department of Otolaryngology, University of Foggia, Foggia, Italy
Salvatore Musto Department of Otolaryngology, University of Foggia, Foggia, Italy
Michele Cassano Department of Otolaryngology, University of Foggia, Foggia, Italy

DOI: https://doi.org/10.23750/abm.v94i4.14152

Keywords:

Chronic rhinosinusitis with nasal polyps, Nasal Cytology, SNOT-22, TNPS, Clinical-Cytological Grading

Abstract

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a chronic inflammatory disease of the nose and the paranasal sinuses characterized by the presence of nasal polyps and persistent symptoms of nasal obstruction, anterior or posterior rhinorrhea, facial pain or pressure, and reduction or loss of smell, lasting longer than 12 weeks. Several therapeutic strategies are nowadays available to treat CRSwNP as a function of disease severity. However, a standardized therapeutic algorithm has not yet been proposed. Since CRSwNP severity can be assessed by the Clinical-Cytological Grading (CCG) and the consequent reduction in patients’ Quality of Life can be defined with the Sino Nasal Outcome Test-22 (SNOT-22), we aimed to propose a new diagnostic-therapeutic algorithm, that takes into consideration both the characteristics of the patients, including the CCG, nasal obstruction, and SNOT-22, and all the therapies available today.

References

Gelardi M, Netti GS, Giancaspro R, et al. Chronic rhinosinusitis with nasal polyposis (CRSwNP): the correlation between expression of Galectin-10 and Clinical-Cytological Grading (CCG). Am J Rhinol Allergy 2022; 36:229-237. doi: 10.1177/19458924211049867.

Shaghayegh G, Cooksley C, Ramezanpour M, et al. Chronic Rhinosinusitis, S. aureus Biofilm and Secreted Products, Inflammatory Responses, and Disease Severity. Biomedicines 2022; 10(6):1362. doi: 10.3390/biomedicines10061362.

Fokkens WJ, Lund VJ, Hopkins C, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology 2020; 58(Suppl S29):1-464. doi: 10.4193/Rhin20.600. PMID: 32077450.

Stevens WW, Peters AT, Tan BK, et al. Associations Between Inflammatory Endotypes and Clinical Presentations in Chronic Rhinosinusitis. J Allergy Clin Immunol Pract 2019; 7(8):2812-2820.e3. doi: 10.1016/j.jaip.2019.05.009.

Bachert C, Han JK, Desrosiers MY, Gevaert P, Heffler E, Hopkins C, Tversky JR, Barker P, Cohen D, Emson C, Martin UJ, Shih VH, Necander S, Kreindler JL, Jison M, Werkström V. Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial. J Allergy Clin Immunol 2022;149(4):1309-1317.e12. doi: 10.1016/j.jaci.2021.08.030.

Gelardi M, Porro G, Quaranta V, et al. Clinical-Cytological-Grading and phenotyping in patients with chronic rhinosinusitis with nasal polyps: the relevance in clinical practice. Monaldi Arch Chest Dis 2020; 90(2). doi: 10.4081/monaldi.2020.1277.

Gelardi M, Fiorella R, Fiorella ML, et al. Nasal-sinus polyposis: clinical-cytological grading and prognostic index of relapse. J Biol Regul Homeost Agents 2009;23(3):181-8.

Gelardi M, Piccininni K, Quaranta N,et al. Olfactory dysfunction in patients with chronic rhinosinusitis with nasal polyps is associated with clinical-cytological grading severity. Acta Otorhinolaryngol Ital. 2019 Oct;39(5):329-335. doi: 10.14639/0392-100X-2426.

Hopkins C. Chronic Rhinosinusitis with Nasal Polyps. N Engl J Med 2019;381(1):55-63. doi: 10.1056/NEJMcp1800215.

Jeong SS, Chen T, Nguyen SA,. Correlation of polyp grading scales with patient symptom scores and olfaction in chronic rhinosinusitis: a systematic review and meta-analysis. Rhinology 2022. doi: 10.4193/Rhin22.011. Epub ahead of print. PMID: 35438689.

Husain Q, Hoehle L, Phillips K, et al. The 22-Item Sinonasal Outcome Test as a Tool for the Assessment of Quality of Life and Symptom Control in Allergic Rhinitis. Am J Rhinol Allergy 2020;34(2):209-216. doi: 10.1177/1945892419884789.

Racette SD, Schneider AL, Ganesh M, et al. CRS-PRO and SNOT-22 correlations with type 2 inflammatory mediators in chronic rhinosinusitis. Int Forum Allergy Rhinol 2022. doi: 10.1002/alr.23002. Epub ahead of print.

Gelardi M, Iannuzzi L, De Giosa M, et al. Non-surgical management of chronic rhinosinusitis with nasal polyps based on clinical-cytological grading: a precision medicine-based approach. Acta Otorhinolaryngol Ital 2017; 37(1):38-45. doi: 10.14639/0392-100X-1417.

Schneider AL, Racette SD, Kang AK, et al. Use of intraoperative frontal sinus mometasone-eluting stents decreased interleukin 5 and interleukin 13 in patients with chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol 2022. doi: 10.1002/alr.23005. Epub ahead of print.

Schlosser RJ, Soler ZM. Evidence-based treatment of chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy 2013; 27(6):461-6. doi: 10.2500/ajra.2013.27.3982.

Desrosiers M, Mannent LP, Amin N, et al. Dupilumab reduces systemic corticosteroid use and sinonasal surgery rate in CRSwNP. Rhinology 2021; 59(3):301-311. doi: 10.4193/Rhin20.415.

Brescia G, Zanotti C, Parrino D, et al. Nasal polyposis pathophysiology: Endotype and phenotype open issues. Am J Otolaryngol 2018; 39(4):441-444. doi: 10.1016/j.amjoto.2018.03.020.

Gan EC, Habib AR, Hathorn I, et al. The efficacy and safety of an office-based polypectomy with a vacuum-powered microdebrider. Int Forum Allergy Rhinol 2013;3(11):890-5. doi: 10.1002/alr.21198.

Tsang GF, McKnight CL, Kim LM, et al. Exploring the psychological morbidity of waiting for sinus surgery using a mixed methods approach. J Otolaryngol Head Neck Surg 2016; 45(1):36. doi: 10.1186/s40463-016-0149-z.

Viera-Artiles J, Corriols-Noval P, López-Simón E, et al. In-office endoscopic nasal polypectomy: prospective analysis of patient tolerability and efficacy. Eur Arch Otorhinolaryngol 2020; 277(12):3341-3348. doi: 10.1007/s00405-020-06196-0.

Hellings PW, Verhoeven E, Fokkens WJ. State-of-the-art overview on biological treatment for CRSwNP. Rhinology 2021;59(2):151-163. doi: 10.4193/Rhin20.570.

Lou H, Wang C, Zhang L. Endotype-driven precision medicine in chronic rhinosinusitis. Expert Rev Clin Immunol 2019; 15(11):1171-1183. doi: 10.1080/1744666X.2020.1679626.

De Corso E, Bilò MB, Matucci A, et al. Personalized Management of Patients with Chronic Rhinosinusitis with Nasal Polyps in Clinical Practice: A Multidisciplinary Consensus Statement. J Pers Med 2022; 12(5):846. doi: 10.3390/jpm12050846.